STC Biologics, Inc is a boutique turn-key CDMO located in Newton MA, USA that provides full CMC Services and Consulting to enable partners advance their biologic products from discovery to commercialization. STC was founded in 2009 and its team brings expertise in biologics drug development and global regulatory approvals from Genentech, Novartis, Shire, EMD Serono, Lonza, Alexion, and Merrimack. The holistic view of drug development with the integration of biology into CMC development, and the cross-training of its scientists in those diverse fields is what makes STC unique in its ability to expedite timelines to the clinic.